Abstract
We determined the human papillomavirus (HPV) types present in invasive cervical cancer (ICC) of women in Cameroon in order to estimate the potential efficacies of HPV prophylactic vaccines. This is a retrospective study using 181 formalin-fixed paraffin-embedded cervical tissue samples of ICC collected from the Institute of Pathology, Gyneco-Obstetric and Pediatric Hospital, Yaoundé, Cameroon. HPV was detected by PCR using modified GP5+/GP6+ (MGP) primers. Genotyping was performed by reverse-blot hybridisation, which allowed the detection of 9 of the 14 high-risk HPV types. Of the 181 samples, 91.7% were squamous cell carcinomas and 6.6% were adenocarcinomas. Counting all the single and multiple infections, the three most common high-risk types in descending order were HPV16 (88%), HPV45 (32%) and HPV18 (14.8%). 54.9% of cases were infected with a single HPV type and 45.1% had two or more HPV infections. The frequencies of HPV16, HPV45 and multiple infections are all higher than previously reported. These observations have significant implications on the consideration of vaccination strategies because each vaccine has different duration and efficacies in cross-protection of different HPV types. The method used proved to be sens...Continue Reading
References
Mar 22, 2001·British Journal of Cancer·M A NobbenhuisT J Helmerhorst
Jul 10, 2003·Acta Obstetricia Et Gynecologica Scandinavica·Grazyna A StanczukAnna-Lise Williamson
Jul 8, 2005·Journal of Clinical Microbiology·Anna Söderlund-StrandLena Dillner
Jul 13, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Helen TrottierEduardo L Franco
Apr 4, 2007·International Journal of Cancer. Journal International Du Cancer·Jennifer S SmithGary M Clifford
Jan 4, 2008·Cancer Research·Svetlana VinokurovaMagnus von Knebel Doeberitz
Jan 16, 2009·Journal of Clinical Microbiology·Anna Söderlund-StrandJoakim Dillner
Jun 19, 2009·British Journal of Cancer·N KeitaS Franceschi
Oct 27, 2009·Human Vaccines·Sven-Eric OlssonRichard M Haupt
Feb 20, 2010·Infectious Diseases in Obstetrics and Gynecology·Andrew J DesruisseauEdith Welty
May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Ni LiGary M Clifford
Jun 4, 2010·Drugs·Suzanne M Garland, Jennifer S Smith
Oct 19, 2010·The Lancet Oncology·Silvia de SanjoseUNKNOWN Retrospective International Survey and HPV Time Trends Study Group
Nov 12, 2010·The Journal of Infectious Diseases·Laia BruniSilvia de Sanjosé
Feb 11, 2011·Human Vaccines·Barbara Romanowski
Aug 13, 2011·Journal of Clinical Microbiology·C EstradeR Sahli
Oct 20, 2011·BMC Women's Health·Catherine McCareyPatrick Petignat
Feb 11, 2012·International Journal of Cancer. Journal International Du Cancer·Peng GuanGary M Clifford
Aug 18, 2012·Virology Journal·Tracy L MeiringAnna-Lise Williamson
Aug 28, 2012·The Lancet Infectious Diseases·Talía MalagónMarc Brisson
Oct 30, 2012·Journal of the National Cancer Institute·Nicolas Van de VeldeMarc Brisson
Dec 29, 2012·International Journal of Preventive Medicine·Mohammad Reza MaracyMaryam Tirani
Feb 19, 2013·PloS One·Marina MunozManuel A Patarroyo
Citations
Sep 10, 2016·Infectious Agents and Cancer·Pamela Boundzanga MoussavouNicolas Berthet
Dec 25, 2015·PloS One·Xing WeiXiaofeng Yang
Jun 5, 2018·Journal of Clinical Laboratory Analysis·Feiyan XiangYun Xiang
Oct 19, 2017·BMC Cancer·Dorcas Obiri-YeboahPhilippe Mayaud
Mar 3, 2020·Frontiers in Cellular and Infection Microbiology·Cameron KleinPeter C Angeletti